according to the American Cancer Society. Dostarlimab—known generically as Jemperli—was developed by GSK in partnership with the biotech firm AnaptysBio in 2014, as the company expanded into ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

GlaxoSmithKline (GSK) plans to take a blood cancer antibody ... pre-treated multiple myeloma patients, presented at the American Society for Hematology (ASH) conference, was therefore hotly ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

GSK and Merck ... endometrial cancer. Results of GSK’s RUBY trial of Jemperli (dostarlimab) and Merck’s NRG-GY018 study of Keytruda (pembrolizumab) were presented at the Society of ...

Biotech giant GSK has announced a potential breakthrough in the treatment of relapsed or refractory multiple myeloma, a type of blood cancer ... the American Society of Clinical Oncology (ASCO ...

U.K. drugmaker GSK on Wednesday cut its vaccine sales guidance for the year, citing lower-than-expected demand. The company said it’s now expecting a low single-digit fall in vaccine sales this ...

GSK says it plans to seek FDA approval for ... How common is cervical cancer and how deadly? The American Cancer Society predicts that in 2007, there will be about 11,150 new U.S. cases of ...

GSK GSK-1.51%decrease; red down pointing triangle cut its full-year vaccine sales outlook after key shots for respiratory syncytial virus and shingles missed expectations in the third quarter due ...

With a rich background in brand positioning, Laura brings a wealth of strategic experience partnering with renowned organizations including Keurig Dr Pepper, Nestle, American Cancer Society, Merck, ...